BW
BWAY.O
—
NASDAQ
Health Care Equipment & Supplies
Brainsway Ltd
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
—
P/E
—
EV / Rev
—
Div yield
—
Op margin
—
ROE
—
Net margin
—
Debt / equity
—
Beta
—
52w range
—
Volume
—
Day range
—
Prev close
$15,97
Open
—
Next earnings
—
Ex-dividend
—
TR 1Y
—
About
Brainsway Ltd operates in the Health Care Equipment & Supplies industry, though specific product details and revenue generation mechanisms are not disclosed in the available data.
Business. Brainsway Ltd (BWAY.O) is a health care equipment and supplies company that develops and commercializes non-invasive neuromodulation devices. The firm is headquartered in Israel and is primarily listed on the NASDAQ stock exchange. As specific operating segment and geographic revenue data are not provided, the company is described at the industry level as a provider of medical technology solutions.
Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
Generated · model-assisted
Sell-side consensus
—consensus pending
— buy— hold— sell
Avg 12m price target—
At a glance
Score
—
not yet scored
Valuation
—
valuation pending
Analysts
—
not yet wired
Ownership
—
not yet wired
Profitability
—
not yet wired
Quality
—
not yet scored
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
— missing data
News & coverage
0Sector rotation
Sector1D1Mvs mkt
Materials+2,3 %+6,6 %+1,7 %
Communication Services+2,2 %−5,5 %+1,6 %
Energy+0,6 %+3,3 %+0,0 %
Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
Information Technology+0,6 %+6,7 %+0,0 %
Consumer Discretionary+0,4 %+7,6 %−0,2 %
Financials−0,3 %−2,8 %−0,9 %
Consumer Staples−0,4 %+2,5 %−1,0 %
Real Estate−0,7 %+10,9 %−1,3 %
Industrials−1,9 %−3,1 %−2,5 %
Utilities−1,9 %+28,2 %−2,5 %
Developing storylines
No tracked sagas currently linked to BWAY.O. Browse all sagas →
Analysis
AI analysis
Generated · analysis pipeline · tier hybrid · as of 2026-08-04
↑ At a glance
Opportunity
— missing data
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
— missing data
Signals & dispatch
peak dispatch · —
Composite-score breakdown
Synthesis
Business
Brainsway Ltd (BWAY.O) is a health care equipment and supplies company that develops and commercializes non-invasive neuromodulation devices. The firm is headquartered in Israel and is primarily listed on the NASDAQ stock exchange. As specific operating segment and geographic revenue data are not provided, the company is described at the industry level as a provider of medical technology solutions.
Classification85 %
SectorHealth Care
Industry groupHealth Care Equipment & Supplies
AI synthesis
GENERATED(a) Capital structure and liquidity cannot be assessed due to the absence of balance-sheet line items and valuation ratios in the provided data. The risk assessment explicitly notes that liquidity risk could not be evaluated because no balance-sheet inputs are present.
(b) Profitability and return metrics are unavailable for analysis. There are no financial snapshot values for revenue, profit, or cash flow, nor are there valuation snapshot ratios such as P/E, ROE, or ROA to compare against cohort medians or industry standards.
Key takeaways
- Liquidity and solvency metrics are entirely absent, preventing any assessment of financial health.
- Dilution risk is low, as basic and diluted share counts are identical.
- Customer concentration signals exist in IR data but lack contextual definition for risk quantification.
- No historical financial performance data is available to evaluate growth or profitability trends.
- The company is firmly classified in Health Care Equipment & Supplies with high confidence.
Bull / Bear case
Generated · model-assisted— missing data
In focus — financials by report
Valuation
Market price
$15,81
Market cap
—
Enterprise valueⓘ
—
P/Eⓘ
—
Non-GAAP P/Eⓘ
—
EV / Revenueⓘ
—
EV / Op incomeⓘ
—
EV / OCFⓘ
—
P / Bⓘ
—
P / Tangible bookⓘ
—
Tangible book
—
Net cashⓘ
—
Current ratioⓘ
—
Debt / equityⓘ
—
ROAⓘ
—
ROEⓘ
—
Cash conversionⓘ
—
CapEx / revenueⓘ
—
SBC / revenueⓘ
—
Dilution ratioⓘ
0.0%
Revenue by segment
Business relationships
Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
Customers1
ANON:CUST:BWAY.O:CustomerAANON:CUST:BWAY.O:CustomerACustomer88%Source ↗
Supply chain
Vendors → BWAY ↔ Partners → Customers · click any node to drill
1 mention in 10-K0 from corporate websites0 from news dispatches
Updated 2026-07-04Peer comparison
— missing data
Market position
Stress test
— missing data
Predictor forecast
Options
— missing data
Short squeeze
— missing data
Earnings-call key lines
— missing data
Consensus distribution
sell-side coverageRecommendation distribution3 analysts
Strong buy2
Buy1
Hold0
Sell0
Strong sell0
12-month price target$17,67 · Median $18,00
Low $17,00High $18,00
Operating income · consensus10,2M USD
EPS surprise
−34,8 %
reported vs consensus · miss
Revenue surprise
−22,8 %
reported vs consensus · miss
Estimate revisions
consensus EPS · 26-week trend— missing data
Sell-side observations
Low$17,00
Mean$17,67
Median$18,00
High$18,00
Spot$15,81
+11.7 %implied to mean12-month sell-side price targets · ▲ spot
Themes
— missing data
ESG
— missing data
Risk factors
Dilution riskLow
Liquidity riskUnknown
Benchmarks vs cohort
No cohort benchmark data available for this issuer yet.
Corporate actions / M&A
— missing data
FX exposure
— missing data
Comparable transactions
— missing data
Derivatives & instruments
Derivative transactions
Net disposed 35 000 sh3 exercises2 insiders
- Chief Technology Officer · Stock Options (right to buy) → Ordinary SharesDisposed 7 500exercise · 2026-05-25
- Director · Stock Options (right to buy) → Ordinary SharesDisposed 17 500exercise · 2026-05-20
- Director · Stock Options (right to buy) → Ordinary SharesDisposed 10 000exercise · 2026-05-19
Actions
Ask Handelsavisen
— missing data
Data sources
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
How metrics are computed
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
Source documents
- Brainsway Ltd. Market data — financials · 2026-07-27
- reconciler_enqueue (reconciler) on BWAY.O · 2026-07-27
- Brainsway Ltd HA canonical relationships · 2026-07-27
Ownership & reference
Insider activity
Mixed / flat0 buys · 6 sellsnet $03 insiders · last 365d
- Chief Technology Officer · Ordinary SharesSold 5 000 · 2026-06-15
- Chief Scientist · Ordinary SharesSold 2 000 · 2026-06-02
- Chief Scientist · Ordinary SharesSold 1 000 · 2026-06-02
- Chief Scientist · Ordinary SharesSold 2 000 · 2026-06-01
- Director · Ordinary SharesSold 7 980 · 2026-05-26
- Chief Technology Officer · Ordinary SharesOther 1 902 · 2026-05-25
- Chief Technology Officer · Ordinary SharesOther 7 500 · 2026-05-25
- Director · Ordinary SharesSold 10 000 · 2026-05-25
- Director · Ordinary SharesOther 6 080 · 2026-05-20
- Director · Ordinary SharesOther 17 500 · 2026-05-20
- Director · Ordinary SharesOther 10 000 · 2026-05-19
- Director · Ordinary SharesOther 3 440 · 2026-05-19
Short positioning
— missing data
Geographic breakdown
— missing data
Listings · one canonical issuer
all listings resolve to the canonical
BWAY.OCanonical
NASDAQ · USD
Intel & risk
peak dispatch · —
OSINT findings
Dilution riskLow
Liquidity riskUnknown
Relationship graph
This companySectorCustomers
Evidence & claims
From filings & derived data— missing data
The Thread
Everything we know, in order2026-06-15 00:00 UTCINSIDER4 insider transactions — 2026-06
2026-06-15INSIDERMoiseyev Gilad sold 5.0k sh Ordinary Shares — Chief Technology Officer
2026-06-02INSIDERRoth Yiftach sold 2.0k sh Ordinary Shares — Chief Scientist
2026-06-02INSIDERRoth Yiftach sold 1.0k sh Ordinary Shares — Chief Scientist
2026-06-01INSIDERRoth Yiftach sold 2.0k sh Ordinary Shares — Chief Scientist
2026-05-26 00:00 UTCINSIDER11 insider transactions — 2026-05 3 derivative
2026-05-26INSIDERMitrany Rayten Michal Ety sold 8.0k sh Ordinary Shares — Director
2026-05-25INSIDERMoiseyev Gilad transacted 1.9k sh Ordinary Shares — Chief Technology Officer
2026-05-25INSIDERMoiseyev Gilad transacted 7.5k sh Ordinary Shares — Chief Technology Officer
2026-05-25INSIDERMitrany Rayten Michal Ety sold 10.0k sh Ordinary Shares — Director
2026-05-25INSIDERMoiseyev Gilad disposed of 7.5k sh Stock Options (right to buy) — Chief Technology Officer
2026-05-20INSIDERMitrany Rayten Michal Ety transacted 6.1k sh Ordinary Shares — Director
2026-05-20INSIDERMitrany Rayten Michal Ety transacted 17.5k sh Ordinary Shares — Director
2026-05-20INSIDERMitrany Rayten Michal Ety disposed of 17.5k sh Stock Options (right to buy) — Director
2026-05-19INSIDERMitrany Rayten Michal Ety transacted 10.0k sh Ordinary Shares — Director
2026-05-19INSIDERMitrany Rayten Michal Ety transacted 3.4k sh Ordinary Shares — Director
2026-05-19INSIDERMitrany Rayten Michal Ety disposed of 10.0k sh Stock Options (right to buy) — Director
The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04
Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data
Premium coverage